Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$532K Sell
1,470
-9
-0.6% -$3.08K 0.3% 56
2026
Q1
$522K Sell
1,479
-54
-4% -$19.3K 0.34% 53
2025
Q4
$502K Buy
1,533
+91
+6% +$28.9K 0.3% 58
2025
Q3
$407K Buy
1,442
+48
+3% +$13.9K 0.26% 69
2025
Q2
$389K Sell
1,394
-9
-0.6% -$2.55K 0.28% 66
2025
Q1
$437K Sell
1,403
-18
-1% -$5.32K 0.45% 53
2024
Q4
$370K Buy
1,421
+11
+0.8% +$3.26K 0.36% 68
2024
Q3
$454K Buy
1,410
+13
+0.9% +$4.25K 0.46% 54
2024
Q2
$436K Buy
1,397
+20
+1% +$5.88K 0.48% 49
2024
Q1
$390K Sell
1,377
-37
-3% -$10.8K 0.47% 56
2023
Q4
$407K Buy
+1,414
New +$385K 0.53% 48

Other funds holding AMGN

OneFund LLC's AMGN Position: Q2 2026 in Review

OneFund LLC reduced its Amgen (AMGN) stake by 0.61% in Q2 2026, selling an estimated $3.08K and leaving 1,470 shares worth $532K. The position accounts for 0.3% of the portfolio, ranked #56.

OneFund LLC first reported a position in AMGN in Q4 2023 and has held it in 11 quarters since. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • OneFund LLC held 1,470 shares of Amgen worth $532K as of Q2 2026.
  • OneFund LLC sold 9 Amgen shares in Q2 2026, an estimated $3.08K.
  • Amgen made up 0.3% of OneFund LLC's portfolio in Q2 2026, its #56 holding.
  • OneFund LLC first reported a position in Amgen in Q4 2023 and has held it in 11 quarters since.
  • 3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on OneFund LLC's 13F filing for Q2 2026, filed 24 Aug 2026.